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Abstract
Focal and diffuse thyroid abnormalities are commonly
encountered during the interpretation of computed to-
mography (CT) exams performed for various clinical
purposes. These findings can often lead to a diagnostic
dilemma, as the CT reflects the nonspecific appearances.
Ultrasound (US) examination has a superior spatial res-
olution and is considered the modality of choice for
thyroid evaluation. Nevertheless, CT detects incidental
thyroid nodules (ITNs) and plays an important role in
the evaluation of thyroid cancer.
In this pictorial review, we cover a wide spectrum of
common and uncommon, incidental and non-incidental
thyroid findings from CT scans. We also discuss the
most common incidental thyroid findings, best practices
for their evaluation, and recommendations for their
management. In addition, we explore the role of imag-
ing in the assessment of thyroid carcinoma (before and
after treatment) and preoperative thyroid goiter, as well
as localization of ectopic and congenital thyroid tissue.
Teaching Points
• Thyroid disorders tend to have non-specific CTappearances.
• ITNs are common on neck CT.
• ITN management depends on nodule size, age, health status,
lymphadenopathy, and invasion.
• CT is used in assessment of cancer extension, mass effect,
invasion, and recurrence.
• CT plays a role in preoperative planning in patients with
symptomatic goiter.
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Introduction
Thyroid disorders are common and include many entities.
They can be symptomatic, asymptomatic, diffuse, focal,
neoplastic, or non-neoplastic processes. Neck ultrasound
(US), with the prospect of proceeding to fine needle aspi-
ration (FNA), is the first line of investigation; however,
other options are available. Thyroid Uptake Scans using
Tc-99 m or I-123 are typically reserved for specific clin-
ical scenarios. Cross-sectional imaging including comput-
ed tomography (CT) and magnetic resonance imaging
(MRI) detect incidental thyroid nodules (ITNs) and can
be used in the evaluation of thyroid cancers and goiter
[1, 2]. The aim of this article is to provide a pictorial
review of a broad spectrum of incidental and non-
incidental thyroid findings on CT scans.
CT scans of the thyroid: normal anatomy
and imaging techniques
The thyroid gland is a vascular, encapsulated structure
made up of right and left lobes, which are connected at
the midline by the isthmus. Each lobe is about 2 cm thick,
3 cm wide, and 5 cm long. The thyroid apex is located
superiorly at the level of the mid-thyroid cartilage. The
inferior margin of the gland is at the level of the fifth or
sixth tracheal ring. The thyroid gland is encapsulated by
the middle layer of deep cervical fascia and is part of the
visceral space in the infrahyoid neck. It wraps around the
trachea and is separated from the oesophagus by the
tracheoesophageal groove on each side, which houses
the recurrent laryngeal nerves. The thyroid has variable
lymphatic drainage to the internal jugular chain, para-
tracheal region, mediastinum, and retropharyngeal area.
It has homogeneous high attenuation values on a CT scan,
as compared to adjacent muscles, due to its high iodine
concentration. It shows avid iodine contrast enhancement
due to its hypervascularity [1, 3].
Multi-detector volumetric acquisition from the skull
base to the tracheal bifurcation is usually obtained.
Multiplanar 2-mm axial, coronal, and sagittal images are
typically available. Examination can be acquired with or
without administration of intravenous (IV) iodinated
contrast.
Incidental thyroid findings on CT scan
The thyroid gland can have variable CT scan findings, such as
calcifications, single or multiple nodules, cysts, or diffuse
enlargement.
Thyroid calcifications on a CT scan can be seen in both
benign and malignant thyroid lesions [1]. Sonographic ex-
amination of the thyroid can differentiate between micro-
calcifications, which are highly associated with papillary
thyroid carcinoma, and eggshell calcifications, which fa-
vour a benign process such as colloid cysts (Figs. 1 and 2)
[4]. In a retrospective review of preoperative CT scan,
35 % (135 of 383) of the patients had detectable intra-
thyroidal calcifications. Among them, 48 % had a histo-
pathologically proven thyroid cancer. Calcified nodules
had a significantly higher incidence of thyroid cancer and
lymph node metastases. The incidence of thyroid cancer
among nodules with different calcifications patterns were
79 % of nodules with multiple punctate calcifications,
58 % of nodules with a single punctate calcification,
21 % of nodules with coarse calcification, and 22 %
of nodules with peripheral calcification. Most of the
single calcified nodules were malignant [5]. However,
this did not include patients with ITNs and the sample
is skewed towards malignancy. Another study evaluated
the presence of ITNs on CT scans and found that 12 %
of thyroid nodules were calcified, with no significant
correlation between malignant or potentially malignant
histology and punctate calcifications [6]. As a result,
some researchers believe that calcification per se is not
a suspicious CT sign, and have suggested that calcified
thyroid nodules on CT scans should be treated the same
as non-calcified nodules [7].
Thyroid cystic changes are variable, ranging from sim-
ple cysts with a thin wall to complex cysts with septations
and solid components. An adenoma may undergo cystic
degeneration. It is important to note that papillary carci-
noma may mimic a benign-looking cyst. Simple serous
cysts appear with fluid density on a CT scan, whereas a
cyst with haemorrhage or high thyroglobulin content is
iso-dense to muscle [1].
Thyroid nodules that are detected by an imaging study but
have not been previously detected or suspected clinically are
considered to be ITNs. ITNs are one of the most common
incidental findings on neck imaging. ITNs are reported in up
to 25 % of chest CT scans, and in 16–18 % of cervical region
cross-sectional imaging, including CT and MRI scans. The
rate of malignancy in the detected ITNs on CTand MRI scans
varies from 0 % to 11 % [6, 8–10]. Incidentally detected thy-
roid carcinomas are more likely to be papillary thyroid carci-
nomas (PTCs) (Fig. 3). Incidentally detected cancers tend to
be smaller in size and less likely to have distant metastasis, as
compared to clinically suspected thyroid cancers [11].
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On CT scans, a malignant lesion is suspected when the
margins are ill-defined and there is extra-thyroid exten-
sion, lymph node involvement, or invasion of the sur-
rounding structures. The absence of these features does
not exclude malignant tumours, especially papillary, fol-
licular, and medullary thyroid carcinomas (Fig. 3) [1].
Therefore, ultrasound is the modality of choice for thyroid
lesion evaluation, due to its superior spatial resolution
compared to CT examinations. Sonographic features of
malignancy are micro-calcifications, acoustic shadowing,
anti-parallel orientation, marked hypoechogenicity, irreg-
ular or microlobulated margins, and increased vascularity.
CT scans lack the ability to detect these reliable sono-
graphic signs of malignancy. Therefore, further manage-
ment of ITNs, if required, usually begins with thyroid
ultrasound and FNA should be considered according to
the ultrasound findings [4, 12–15].
The American College of Radiology (ACR) flowchart
and recommendations for ITNs detected by CT or MRI
offer general guidance and are not applicable to all pa-
tients. The recommendations are primarily based on the
presence or absence of suspicious features, nodule size,
patient’s age, patient’s life expectancy, and patient’s co-
morbidities [11]. Suspicious features that can be detected
on CT scans include signs of local invasion and abnormal
lymph nodes. Abnormal lymph nodes may show cystic
components, calcifications, and/or increased enhance-
ment. Mere nodal enlargement is less specific for thyroid
cancer metastasis; however, further evaluation should be
considered if the ITN has ipsilateral jugulo-digastric
lymph nodes > 1.5 cm on the short axis or > 1 cm for
other groups. Cervical Level IV and VI lymphadenopa-
thies raise a higher suspicion of thyroid carcinoma metas-
tasis. Almost all patients with ITNs and suspicious imag-
ing features should be evaluated with a neck ultrasound.
Patients with comorbidities or limited life expectancy
without suspicious features should not undergo further
evaluation. Nevertheless, further workup might be
Fig. 2 A 51-year-old female patient post left hemi-thyroidectomy, with
incidentally discovered right thyroid colloid nodule on CT scan. a
Enhanced axial CT scan of the neck demonstrates a well-defined,
hypodense right thyroid nodule (white arrow) with no internal
calcifications or cervical lymphadenopathy. b Transverse greyscale
thyroid ultrasound demonstrates a well-defined, hypoechoic right
thyroid lobe nodule with a central echogenicity including comet tail
(ring down) artefacts (white arrow). No vascularity (not shown) or
calcifications were detected
Fig. 1 An incidentally discovered colloid nodule with calcification,
shown on CTscan of a 58-year-old female patient. a Non-enhanced axial
CT scan of the neck demonstrates a coarse calcification at the left thyroid
inferior pole. b Sagittal grey scale ultrasound of the thyroid demonstrates
a heterogeneous nodule with predominant cystic component.
Calcification was not seen in the ultrasound, probably due to its lower
location in the superior mediastinum
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necessary for such individuals if it is clinically warranted,
or specifically requested by the referring physician or the
patient [11].
In patients with ITNs, it is important to inquire about
pertinent historical factors predicting malignancy. These
factors include history of childhood or adolescent head
and neck or total body radiation exposure, and familial
thyroid carcinoma or thyroid cancer syndrome.
Syndromes associated with thyroid cancer include multi-
ple endocrine neoplasia 2, familial adenomatous
polyposis, Carney complex, Cowden’s disease, and
Werner syndrome/progeria. If a patient has a first-degree
relative with such a syndrome, screening based on the
various components of that syndrome is advised.
Nevertheless, there are no guidelines specifically address-
ing ITNs detected on CT scans in patients at risk of thy-
roid cancer. Therefore, in the absence of suspicious fea-
tures on the CT scan, other criteria such as nodule size on
the CT scan, patient age, and levels of thyroid stimulating
hormone (TSH) are important in guiding management in
such a patient population [16].
Although the correlation between thyroid nodule size
and malignancy risk is limited, nodule size affects prog-
nosis in malignant nodules [13]. Small thyroid cancers
(less than 2 cm) tend to have an indolent course, with
favourable prognosis even if not treated [9, 17]. Less than
7 % of the imaging-detected ITNs are seen in younger
populations [6, 9, 18]. However, Shetty et al. [6] found
a higher rate of malignancy in the ITNs detected on CT
scans among patients younger than 35 years. Ito et al. [19]
found a higher tumour progression risk among young pa-
tients (<40 years) with subclinical, low-risk PTCs who
undergo observation rather than surgery. Therefore, nod-
ule size and patient age should determine the need for
workup in the general population without suspicious im-
aging features and with normal life expectancy. Further
evaluation with ultrasound is required for patients less
than 35 years old with nodules measuring more than
1 cm in the axial plane. The cutoff size for further evalu-
ation is raised to 1.5 cm for patients more than 35 years
old. This recommendation should be applied to the largest
thyroid nodule in cases of multiple thyroid nodules.
Incidentally discovered heterogeneous and enlarged thy-
roid glands should undergo dedicated ultrasound if the




Primary thyroid carcinomas include papillary, follicular, medul-
lary, and anaplastic carcinomas. Lymphoma and metastasis of
other primary malignancies to the thyroid gland represent a mi-
nority of thyroid carcinomas. Differentiated thyroid carcinomas
(DTCs) originate from follicular epithelial cells and encompass
PTCs and follicular thyroid carcinomas, including the Hurthle
Fig. 3 An incidental PTC in a
62-year-old male patient with
lymphoma. a, b Enhanced axial
CT scan and fused PET/CT scan
of the neck demonstrate a well-
defined, hypodense right thyroid
nodule (white arrow) with high
FDG uptake. The FDG-avid
uptake in the left side (circle) is
related to patient’s known
lymphoma, which resolved after
treatment. c, d Transverse
greyscale and sagittal colour
Doppler ultrasound of the neck
demonstrate a right thyroid
irregular hypoechoic lesion with
some micro-calcifications (white
arrows) and increased vascularity
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cell variant of follicular carcinoma.DTCs have an excellent prog-
nosis and fortunately represent the majority of thyroid carcino-
mas. PTCs and follicular thyroid carcinomas represent 88 % and
8 %, respectively, of all thyroid malignancies. Medullary thyroid
carcinoma arises from neuroendocrine C-cells and has a good
prognosis. Anaplastic carcinoma is an aggressive undifferentiat-
ed tumour that usually affects the elderly and tends to have a
worse prognosis [1, 2, 20, 21].
Role of imaging
Surgery is the primary mode of treatment for DTCs. Post
total thyroidectomy radioactive iodine (RAI) ablation is
an option, especially in patients with distant metastasis,
tumours larger than 4 cm, or extra-thyroidal disease ex-
tension. Ultrasound examination is usually adequate in
evaluating primary tumours and cervical lymph nodes.
Preoperative cross-sectional imaging with CT or MRI is
indicated if there is a concern for local invasion that may
alter the patient’s staging as well as surgical approach
(Figs. 4, 5 and 6) [2]. Some thyroid primaries may be
small, diffuse, or multifocal and therefore may be occult
on imaging (Fig. 4) [6].
In patients with known thyroid malignancies, a non-
enhanced exam is preferred due to the possible undesired in-
terference of free iodide contrast medium with thyroid iodide
I-131 uptake for 6–8 weeks or more [22, 23]. This would
adversely affect the management of these patients by delaying
diagnostic thyroid scintigraphy and radioiodine ablation in
patients with DTCs for 2–6 months.
The radiologist must evaluate the central structures
draping the thyroid gland including the trachea, oesopha-
gus, larynx, and pharynx, as well as the recurrent laryn-
geal nerve. Invasion is suspected if the thyroid mass abuts
the airway or oesophagus for more than 180 degrees.
Luminal deformity, mucosal thickening, and mucosal fo-
cal irregularity are more specific indicators of invasion.
Obliteration of the fat planes of the tracheoesophageal
groove in three axial images and signs of vocal cord pa-
ralysis are indicative of recurrent laryngeal nerve inva-
sion. Invasion of these central structures meets the criteria
for T4a disease (Figs. 5 and 6) [2].
Arterial invasion constitutes T4b disease, whichmay preclude
curative surgery. More than 180 degrees of arterial encasement is
suggestive of invasion, however, arterial deformity or narrowing
ismuchmore suspicious for invasion [2]. The carotid artery is the
most commonly involved artery; however, the mediastinal ves-
sels should also be examined. Encasement of the carotid artery or
mediastinal vessels for more than 270 degrees is unlikely to be
resectable [24]. On the other hand, occlusion or effacement of the
internal jugular vein can occur without invasion and does not
influence surgical resectability or staging. Asymmetry of the
strap muscle and the tumour abutting its external surface are
signs of invasion. However, invasion of the pre-vertebral muscu-
lature is more challenging, as a large lesion can compress the
muscle without invasion (Figs. 5 and 6) [2, 25].
Finally, the possibility of metastatic disease should be exclud-
ed. PTCs and medullary thyroid carcinomas tend to metastasize
to regional lymph nodes. According to the AJCC/UICC TNM
staging system, the nodal stage is classified by site: N1a indicates
level VI nodal involvement, including paratracheal nodes; N1b
indicates unilateral or bilateral lateral cervical nodal disease or
superior mediastinal nodal disease (Figs. 4, 5 and 6) [2, 25].
The incidence of hematogenous spread of follicular carcino-
mas is 21–33 % and that of PTCs is 2–14 % [26, 27]. In medul-
lary thyroid cancer and anaplastic thyroid cancer, distant metas-
tasis was reported in 25 % and 40 % of patients, respectively.
Distant metastases from DTCs tend to have a more favourable
prognosis. Distant metastatic disease may appear years after the
initial presentation. Therefore, imaging for distant metastases is
usually done pre-operatively for anaplastic thyroid cancer and
post-operatively for DTCs. DTC distant metastases sites include
the lung (50%), bone (25%), lung and bone (20%), followed by
other sites (5 %) [28–30].
Fig. 4 A 45-year-old male patient presented with anterior mediastinal
metastatic PTC lesions and occult primary on imaging. Histopathology
examination of the resected thyroid gland revealed micro-foci of PTC; the
largest, in the isthmus, measured 4 mm. a Transverse greyscale
ultrasound of the thyroid demonstrates homogenous gland with normal
echogenicity and size. No focal lesion or micro-calcifications. b Non-
enhanced CT scan obtained as part of PET/CT examination shows a
heterogeneous, large, relatively dense anterior mediastinal mass (white
arrow) with peripheral calcification (arrowheads). Thyroid gland has
normal CT appearance with no abnormal FDG uptake (not shown)
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Fig. 6 A 61-year-old female patient with locally aggressive PTC. a
Enhanced axial CT scan of the neck demonstrates a heterogeneous
infiltrative thyroid mass. This mass diffusely involves the entire gland
and circumferentially encases the trachea with involvement of bilateral
tracheoesophageal grooves (white arrows). b, c Additional axial cranial
images show right cricoid cartilage destruction (black arrows in b), right
thyroid cartilage destruction (black arrow in c), right vocal cord paralysis
(white arrows in b), and bilateral cervical lymphadenopathy
(arrowheads)
Fig. 5 A poorly differentiated invasive left thyroid mass in a 58-year-old
female patient. a Sagittal greyscale neck ultrasound shows a large
hypoechoic lesion with macro-calcification and micro-calcification. b
Sagittal colour Doppler ultrasound shows left internal jugular vein
filling defect with detected internal vascularity suggestive of tumour
thrombus. c Enhanced axial and coronal CT scans of the neck show
heterogeneously enhancing large lesion replacing the left thyroid lobe
and extending to the isthmus and the medial aspect of the right thyroid
lobe (white arrow). Themass and the conglomerate lymph nodes measure
12.5 × 7 × 5.8 cm (white arrows). d, e Axial enhanced CT scans show
enlarged left cervical nodes (white arrow) and left internal jugular vein
(IJV) thrombus (black arrows). Note the IJV distention and central
enhancing portion in the upper cut (black arrow in e) concerning the
tumour thrombus. f, g Enhanced axial CT scan of the upper chest
demonstrate a mass extension into the retrosternal area, left
tracheoesophageal groove, and posterior to the trachea (white arrows in
f). There are multiple bilateral pulmonary nodules (white arrows in g)
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Recurrence
The thyroid cancer recurrence rate is reported to range from 7 %
to 14 % [31, 32]. Recurrence is usually detected within the first
decade after initial disease diagnosis. Large lymph node metas-
tasis is considered the strongest predictor for thyroid cancer re-
currence [31]. Post-treatment surveillance for recurrent disease
depends on cancer type and staging. Patients with DTC are usu-
ally treated with total thyroidectomy and RAI ablation. Patients
should have baseline neck US evaluation at 6–12 months after
the RAI ablation and then periodically, depending on the pa-
tient’s risk for recurrent disease and thyroglobulin (Tg) status.
After the first post-operative RAI ablation, further RAI imaging
is not necessary if the patient has normal neck US, undetectable
Tg level under TSH stimulation, and negative antithyroglobulin
(TgAb). Annual neck USwith or without FNA, along with mea-
surement of serum Tg and serum TgAb, is usually sufficient for
post-treatment surveillance in those patients. Moreover, annual
US is appropriate in patients with medullary cancer and normal
calcitonin levels [2, 16, 33].
The likelihood of positive anatomic imaging is greater
when serum Tg is >10 ng/mL [16]. A diagnostic CTscan adds
additional value to neck US in detecting central compartment
macro-metastases in the mediastinum and retro-tracheal area
[34–36]. According to the recent American Thyroid
Association guidelines [16], an upper chest and neck CT scan
with IV contrast should be obtained when: 1) neck US is
inadequate in visualizing possible local nodal disease (high
Tg, negative neck US, and RAI imaging); 2) US is not able
to delineate the disease completely, as in the case of bulky
recurrent nodal disease; or 3) evaluation of possible recurrent
invasive disease is needed (Figs. 7, 8 and 9). CT scans are also
the most sensitive diagnostic tool for the detection of pulmo-
nary micro-metastases. Many of the neck US features that are
considered as suggestive signs of disease recurrence are also
applicable to CT examination. These signs might include
sizable rounded nodules in the thyroid bed, fine calcifications,
or cystic change [37].
In cases of elevated thyroglobulin with negative neck US
and i o d i n e who l e body s c i n t i g r a p hy (WBS ) ,
fluorodeoxyglucose (FDG) positron emission tomography
(PET) is the next modality of choice. Dedifferentiated thyroid
carcinoma usually has avid FDG-PET uptake and a negative
radioiodine scan, typically does not respond to RAI therapy,
and has a poorer prognosis [2]. There is not yet consensus in
the research literature on whether cross-sectional imaging (CT
or MRI) or an 18FDG-PET/CT scan should be performed as
the first-line imagingmodality for such patients. Enhanced CT
scan was thought to be more sensitive for detection of lymph
node metastases. Nonetheless, scans using modern PET/CT
equipment are as reliable as a proper routine staging CT scan.
Many lesions can be found on 18FDG-PET/CT scanning de-
spite the lack of IV contrast injection. However, differentiation
between local recurrence versus lymph node metastases and
detection of direct involvement of the aerodigestive axis or
vascular structures are not technically possible in the absence
of IV contrast administration. For these reasons, 18FDG-PET/
CT utilizing contrast administration should be considered for
most patients with extensive disease [16, 38–40].
Metastasis to the thyroid
Metastasis to the thyroid is rare and represents 5.5 % of
biopsied thyroid malignancies. It is commonly found with
cancers originating from the breast, renal cell, lung, melano-
ma, and colon. Direct invasion from adjacent structures such
as the pharynx, larynx, trachea, or oesophagus has been re-
ported (Fig. 10). Metastatic disease has a non-specific appear-
ance [1, 2, 20, 21].
Presence of ITNs in patients with another known malig-
nancy is a common clinical problem with controversial man-
agement guidelines. Wilhelm et al. [41] followed 41 patients
Fig. 7 A 51-year-old female patient post total thyroidectomy for PTC
with elevated thyroglobulin measurement. aAxial non-enhanced CTscan
of the neck at the level of the thyroid bed demonstrates a well-defined,
rounded, homogenously dense soft tissue situated between the trachea
and left internal jugular vein (white arrow). b Transverse ultrasound
image of the neck demonstrates a well-defined, homogenous,
hypoechoic soft tissue nodule measuring 6 mm (white arrow) with no
detected micro-calcifications. Biopsy showed a predominantly residual
normal thyroid tissue with micro-foci of PTC
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with a known extra-thyroid malignancy and ITNs; 35 of them
met the criterion for biopsy (nodule ≥ 1 cm). Pathology re-
vealed four papillary thyroid cancers and five micropapillary
thyroid cancers. Only two metastatic cancers were detected.
Clinical history (history of radiation, age, endocrine syn-
dromes), TSH, nodule size, and sonographic features are im-
portant to determine which nodule(s) should be followed or
biopsied. However, existing guidelines do not specifically ad-
dress how to approach ITNs detected on CT scans in such a
specific patient population [41].
Thyroid lymphoma
Thyroid lymphoma represents about 5 % of thyroid malignan-
cies. Non-Hodgkin’s lymphoma is the most common type and
can be secondary to generalized lymphoma or a primary tu-
mour. Primary thyroid lymphoma usually pre-exists with
Hashimoto’s thyroiditis. On CT scans with and without con-
trast, lymphomas tend to have low attenuation values. Thyroid
lymphomas have variable appearance and mostly manifest as
a solitary mass (80 %). They may also manifest as multiple
nodules (15 % to 20%) or as a bulky mass replacing the entire
gland with extra-thyroid extension (Figs. 11 and 12). The
presence of cervical lymphadenopathy supports such a diag-
nosis. Although it is uncommon, tumour necrosis has been
reported [1, 21].
Goiter
A goiter is an abnormal thyroid gland proliferation that man-
ifests as multi-nodular, uni-nodular, or non-nodular diffuse
glandular enlargement. A goiter is formed of solid matrix,
colloid cysts, blood products, calcification, and fibrosis, and
this heterogeneity may lead to variable appearances on a CT
scan (Figs. 13, 14 and 15) [2]. US is more sensitive in evalu-
ating thyroid nodules within a goiter; however, a symptomatic
goiter may require surgical treatment with total thyroidectomy
[42], and in this case CT plays an additional role in preoper-
ative evaluation. Specific aspects for examination on a CT
Fig. 8 A 48-year-old male patient post total thyroidectomy with PTC
recurrence. a Transverse greyscale ultrasound of the neck demonstrates a
left thyroid bed heterogeneous, predominantly hypoechoic irregular
lesion with calcifications (white arrow). b A spot image of iodine 123
total body scan of the neck demonstrate a focus of abnormal radiotracer
uptake at the left thyroid bed (Black arrows) between the annotated
markers. c Enhanced axial CT scan of the neck demonstrates an
enhancing large left thyroid bed mass (white arrow) with no
calcifications. The lesion exerts a mass effect on the oesophagus (black
arrow) and is inseparable from the trachea
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scan during the preoperative evaluation for goiter include ex-
tension, mass effect, and suspicious features of malignancy [2,
43].
Malignancy can coexist within the goiter and a CT scan
may give a clue if there are abnormal cervical lymph nodes
and/or signs of invasion. Retrosternal extension (Fig. 15)
could affect the surgical approach, as a lower extent may re-
quire a partial or total sternotomy to facilitate complete
resection [43]. Therefore, the distance of the retrosternal ex-
tent from the sternal notch should be measured on a sagittal
image.
The interpreting radiologist should describe the mass ef-
fect, detailing its degree and direction of displacement of cen-
tral structures, including the trachea, oesophagus, larynx, and
pharynx. Attention should be directed to the upper extent of
the goiter and structures immediately surrounding the thyroid
Fig. 10 Metastatic squamous cell carcinoma of unknown origin in a 42-year-old female patient. a, b Axial and coronal enhanced neck CT scan
demonstrates infiltrative hypodense left thyroid lobe lesions (white arrows). There are multiple necrotic cervical nodal metastases (white block arrows)
Fig. 9 A 58-year-old male patient with persistence PTC at thyroid bed
with hypervascular nodal metastasis. a–c Transverse greyscale and colour
Doppler neck ultrasound demonstrate hypoehoic soft tissue in the left
thyroid bed (white arrow in a). There are a heterogeneous enlarged
lymph nodes at level 2 and 3 with markedly increased vascularity
(white arrow in b and c). d–f Enhanced axial CT images of the neck
demonstrate a 2.7 × 1.4 cm hypodense soft tissue lesion anterior to the
left carotid sheath (white arrow). There are left-sided enhancing abnormal
and enlarged lymph nodes at cervical level 2 and 3 (black arrows)
Insights Imaging (2016) 7:601–617 609
gland , inc luding the neuro-vascula r s t ruc tures ,
retropharyngeal space, and pre-vertebral space. The reporting
radiologist should evaluate the vocal cords for symmetry and
signs of vocal cord palsy [2, 43].
Inflammatory lesions
Inflammatory thyroid disorders include acute infectious thy-
roiditis, Hashimoto’s thyroiditis, Riedel’s thyroiditis, and
granulomatous thyroiditis (de Quervain’s). Hashimoto’s thy-
roiditis is associated with an increased risk of lymphoma and
papillary thyroid carcinoma. The CT scan findings of thyroid-
itis are nonspecific and variable (Figs. 14, 15 and 16) [1]. The
thyroid gland has a very high iodine concentration, resulting
in high CT attenuation (80–100 Hounsfield Units). The pres-
ence of thyroiditis can be suggested by a diffusely enlarged
and hypo-attenuating (around 45 Hounsfield Units) thyroid
gland. This is probably due to follicular cell destruction and
reduced thyroid iodine concentration. Marked homogenous
enhancement is typically expected. Therefore, moderate thy-
roid enhancement in a case of thyroiditis suggests a diffuse
inflammatory process. It is essential to clinically correlate this
with a thyroid function test and serum autoantibody levels [1,
44].
Ectopic tissue/gland
During embryogenesis, the bi-lobed thyroid migrates inferiorly
from the foramen cecum of the tongue to the lower neck.
Initially, the thyroid primordium passes anterior to the primordial
hyoid bone, before it loops posteriorly and inferiorly to the hyoid
bone. Then it continues its descent into the infra-hyoid portion of
the neck, anterior to the trachea, thyroid cartilage, and thyroid
membrane. Any thyroid residual along the descent course may
lead to the development of ectopic thyroid glands. Thyroid
carcinomas, thyroiditis, and goiter may develop within any ec-
topic thyroid tissue [1, 45–47].
Thyroid scanning with technetium-99 m (Tc99m) plays an
important role in detecting orthotopic and ectopic thyroid tissue.
Both CT scans and US can help detect ectopic tissue when a
lesion demonstrates imaging and enhancement characteristics
of thyroid tissue. The absence of normally sited thyroid gland
in US and CT scans also supports the diagnosis. In addition, US
can guide FNA for cytological confirmation of a thyroid lesion
[46]. Ectopic thyroid tissue appears as a well-circumscribed, ho-
mogeneous, highly attenuatingmass relative to adjacent muscles.
Normally, it enhances avidly following the administration of io-
dinated contrast [1, 45, 47].
Ectopic thyroid tissue may be detected in the tongue near the
foramen cecum (90 %) and along the midline between the thy-
roid isthmus and posterior tongue, lateral neck, mediastinum, and
oral cavity. The most frequent location is the base of the tongue
(Figs. 16, 17 and 18). In 70 % of cases, the ectopic thyroid is the
Fig. 12 Diffuse thyroid large B-cell lymphoma in 79-year-old female
patient. a Axial enhanced neck CT scan demonstrates a homogeneously
hypodense and minimally enhancing large right thyroid solid mass (long
white arrow) extending into the thyroid isthmus. It is encasing the right
carotid artery (short white arrow) and displacing of the trachea and
oesophagus to the left side
Fig. 11 Thyroid non-Hodgkin’s large B-cell lymphoma in a 66-year-old
female patient. a Axial enhanced neck CT scan demonstrates left thyroid
lobe and isthmus homogeneously hypodense and minimally enhancing
mass (white arrows). This lesion invades the prevertebral muscles (black
arrows). Note the multiple enlarged level V lymph nodes (white
arrowheads). b Post-treatment image shows significant reduction in
size and mass effect of the left thyroid infiltrative mass, with almost
complete resolution of the left cervical lymphadenopathy
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only functional thyroid tissue present in the body (Fig. 18) [1, 45,
46].
Ectopic thyroid tissue lateral to the orthotopicmidline location
is rare [46, 48, 49]. The exact anatomical definition of this rare
entity is debated in the literature [48, 50]. To avoid confusion,
some authors define a lateral neck ectopic thyroid as any thyroid
tissue superficial to the strap muscles with no midline continuity
[45]. The majority of lateral thyroid ectopia cases have been
reported as lesions closely related to the strap muscles [48, 49].
There are few reported cases of ectopic lateral thyroid tissue in
the submandibular region [46, 51], jugulodigastric region [52], or
within the parotid gland substance (Fig. 17) [53].
The origin of lateral ectopic thyroid tissue is not fully under-
stood. Although this is controversial, some authors suggest that it
Fig. 14 A 19-year-old male patient known to have multi-nodular goiter
and FNA, showing underlying Hashimoto’s thyroiditis. a, b Sagittal and
transverse greyscale and colour Doppler ultrasound of the neck
demonstrate a hypoechoic enlarged right thyroid lobe with small
hyperechoic regenerative nodules and marked hypervascularity (white
arrows). c, d Enhanced axial CT scan images of the neck demonstrate a
heterogeneously enhancing and enlarged thyroid gland, left more than
right lobe, and the trachea is markedly narrowed
Fig. 13 A 27-year-old female patient known to have goiter. a, b Axial
and sagittal enhanced CT scan images of the neck demonstrate a
heterogeneously enhancing, enlarged thyroid gland with scattered
calcifications (white arrow), cystic changes, and substantial retro-sternal
extension (black asterisks). No lymphadenopathy or substantial airway
narrowing
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might have originated from lateral thyroid anlagen
(ultimobranchial bodies) that failed to fuse with the median an-
lage during caudal migration [46, 48].
A thyroglossal duct cyst (TDC) is a duct remnant between
the foramen cecum and thyroid isthmus. Most TDCs are lo-
cated below the hyoid bone and in the midline. The more
caudal the cyst, the more likely it will be off midline within
2 cm (Fig. 19 and 20). On a CTscan, a TDC appears as a well-
circumscribed area of fluid attenuation with thin walls. The
cyst wall can become thick with an enhancing rim indicative
of current or previous infection. These cysts maybe compli-
cated by haemorrhage, infection, or malignancy. Therefore,
their US and CT scan appearance may vary based on their
content. Nodular enhancement within a TDC should initiate
further workup to exclude malignancy (Fig. 21) [1, 45]. US-
guided FNA of these suspicious nodular areas is considered an
appropriate next diagnostic step, taking into consideration the
high rate of false negative results [54].
Intra-thyroid parathyroid adenoma
Parathyroid adenoma (PA) is the most common cause of pri-
mary hyperparathyroidism. Ectopic parathyroid adenoma is
rare. The third and fourth pharyngeal pouches represent the
embryological origin of the parathyroid tissues, and ectopic
parathyroid adenoma can ultimately develop anywhere along
their migration course. In a large retrospective study of
Fig. 15 A 33-year-old female patient who presented with neck swelling
and pain and was later diagnosed with Hashimoto’s thyroiditis. a Axial
enhanced CT scan of the neck demonstrates minimal diffuse enlargement
of the thyroid gland, especially the isthmus (white arrow). b Transverse
greyscale ultrasound of the neck demonstrates heterogeneously enlarged
thyroid and thickened isthmus, measuring 8.6 mm
Fig. 16 Midline ectopic thyroid with Hashimoto’s thyroiditis in a 49-
year-old female patient. a Transverse greyscale ultrasound shows a
1.6 × 0.8 cm solid, well-defined, heterogeneous area (white arrow) in
the midline, superior to the thyroid gland. It is iso-echogenic to the
thyroid gland with no definite connection to the thyroid gland. b
Transverse colour Doppler ultrasound shows significant increase in
vascularity. c Axial enhanced neck CT scan at the level of thyroid
cartilage demonstrates midline infrahyoid hyperdense soft tissue mass
(white arrow) embedded within the strap muscle
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patients with primary hyperparathyroidism, PA was detected
in the intra-thyroid location in 0.7 % of cases. In another
retrospective analysis of 202 patients with ectopic PA, intra-
thyroidal location was found in 18 % of the cases. Intra-
thyroid parathyroid adenomas mimic thyroid nodules in CT
scans and may even show uptake on a thyroid iodine scan.
Correlation with laboratory workup, including measurement
of serum parathyroid hormone and calcium level, is required.
In addition, the evaluating radiologist should search for radio-
logical manifestations of hyperparathyroidism, such as
osteopenia, bone resorption, and brown tumours (Fig. 22)
[55, 56].
Fig. 17 Ectopic thyroid on the left parotid gland with a palpable left
parotid mass in a 69-year-old male patient. a, b Axial and coronal
enhanced neck CT scan demonstrates well-defined homogeneous
enhancing mass (white arrows) within the left parotid gland with
preserved surrounding fat planes. It also shows a normal thyroid in
normal position in the lower neck. c Image taken 20 minutes after
5 mCi injected Tc99m-Pertechnetate shows normal thyroid uptake of
tracer and physiological uptake in the salivary glands (short black
arrow). There is a distinct focus of abnormal tracer accumulation in the
left parotid/submandibular region. Patient was given lemon juice with
evident normal washout from the salivary glands and relative retention
by this abnormal focus (long black arrow)
Fig. 18 Lingular thyroid in a 33-year-old male who presented with
oropharyngeal bleeding. a Axial enhanced neck CT scan at the level of
mandible demonstrates a 3 × 3 × 3.4 cm round, partly well-delineated,
heterogeneously enhancing lesion (white arrow). It is predominantly on
the left side of the oropharynx and to some extent at the mid part of the
base of the tongue. Thyroid glandwas normal (not shown). b Image of the
anterior face and neck taken 20 minutes after Tc99m-Pertechnetate
injection shows absent thyroid radiotracer uptake in normal thyroid
anatomical location (black short arrows). There is an area of increased
uptake (long black arrows) corresponding to posterior tongue mass
identified on CT scan
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In the case of inconclusive Tc99m Sestamibi and neck US
imaging, FNA biopsy with FNA-iPTH (intact parathyroid
hormone) measurement can provide simultaneous biochemi-
cal and cytological evidence. Elevated FNA-iPTH measure-
ment, as compared to serum iPTH, is considered positive and
diagnostic of parathyroid adenoma [57, 58].
Conclusion
Thyroid disorders are common and tend to have non-specific
appearances on CT scans. Commonly encountered findings
when evaluating a CT scan of the neck include thyroid nod-
ules, glandular enlargement, and calcifications.
Fig. 20 Recurrent/residual thyroglossal duct cyst in a 39-year-old male
patient. The first resection of thyroglossal duct cyst showed
histopathology evidence of Hurthle cell type thyroid cancer. However,
the second resection showed signs of chronic inflammation, with no
malignant cells. a, b Enhanced axial and sagittal neck CT scans
demonstrate a unilocular cystic lesion arising from the tongue base and
extending through the partially resected hyoid bone. This cystic lesion has
peripheral enhancing wall, which becomes more thick over its inferior
aspect associated with surrounding fat stranding at the surgical site (white
arrow). There are no internal septations, nodules or masses, or
calcifications. c Transverse view of power Doppler ultrasound at the
submental area demonstrates cystic lesion and internal debris with no
detected internal vascularity
Fig. 19 Long-standing infected thyroglossal duct cyst in a 29-year-old
male patient. a Transverse greyscale ultrasound at midline, just above the
level of the thyroid gland, shows an oval cystic lesionwith internal echoes
(white arrows) and posterior enhancement (arrowheads). b Transverse
colour Doppler ultrasound shows surrounding peripheral flow (white
arrow). c Axial enhanced neck CT scan at the level of the thyroid
cartilage demonstrates a slightly off-midline, well-defined,
homogeneous cystic lesion embedded in the left strap muscle with
peripheral enhancement (white arrow). It shows no calcification or
internal enhancement. Thyroid gland was normal (not shown)
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Management of ITNs depends on several factors including
nodule size, patient’s age, overall health status, and the
presence or absence of suspicious features such as lymphade-
nopathy and/or invasion of adjacent structures.
Fig. 22 A 26-year-old male patient with elevated serum parathyroid
hormones and calcium secondary to intra-thyroid parathyroid adenoma.
a, b Enhanced axial and coronal CT scan of the neck demonstrate a well-
defined hypodense right thyroid nodule (white arrows). c Bone window
coronal CT scan shows lytic expansile lesions at the right mandible and
left frontal bone (white arrows). d Transverse colour Doppler ultrasound
of the neck demonstrates a well-defined, heterogonous, predominantly
hypoechoic right thyroid nodule measuring 2.7 cm, with mild increased
vascularity and no internal micro-calcifications (white arrow). e, f
Delayed anterior planar and fused SPECT/CT parathyroid Sestamibi
scan at 2 hours demonstrate persistent focal activity in the right thyroid
lobe (white arrows). Note the scattered mandibular/maxillary uptakes in
planar image representing the known brown tumours
Fig. 21 Papillary thyroid carcinoma arising from a thyroglossal duct cyst
in a 28-year-old male. a Axial enhanced CT scan shows a large complex
cystic lesion (white arrows) adherent to the anterior aspect of the hyoid
bone. It has an enhancing mural solid nodules and calcifications (black
arrows). There is no cervical lymphadenopathy. b Axial short tau
inversion recovery (STIR) MRI image near the same level shows
complex lesion of high signal intensity (long white arrows) with solid
mural nodules (short white arrow). c Axial fat saturated T1 MRI image
post contrast administration shows the complex cystic lesion with thick
enhancing wall (long white arrows) and enhancing mural nodules (short
white arrows)
Insights Imaging (2016) 7:601–617 615
A CT scan provides additional important information re-
garding the local extension of cancer or presence of mass
effect, and is useful in evaluating recurrent disease.
Furthermore, CT examination plays a crucial role in preoper-
ative evaluation and preoperative surgical planning for pa-
tients with symptomatic goiter.
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